Clinical Trial Update: Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Milademetan to Trabectedin in dedifferentiated liposarcoma was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma

Drugs mentioned

• Milademetan (milademetan)
• Trabectedin (trabectedin)

Snippet

Sponsor: Rain Oncology Inc | Conditions: Dedifferentiated Liposarcoma | Phase 3 | Status: TERMINATED | Results posted: 2025-01-14